Background: In order to evaluate the safety of acupuncture in China objectively, we investigated the adverse events associated with acupuncture based on three multicentre randomized controlled trials (RCTs) to assess the safety of acupuncture, identifying the common types of acupuncture adverse events, and analysing the related risk factors for their occurrence. Methods: This observational study included patients who received acupuncture from three multicentre RCTs respectively for migraine, functional dyspepsia and Bell's palsy. The 1968 patients and their acupuncturists documented adverse events associated with acupuncture after treatment. We collected data about adverse events due to acupuncture treatment from their case report forms. We analysed the incidence and details of the adverse effects, and studied the risk factors for acupuncture adverse events with non-conditional logistic regression analysis. Results: Among the 1968 patients, 74 patients (3.76%) suffered at least one adverse event throughout the treatment period. We did not observe the occurrence of serious adverse events. 73 patients with adverse events recovered within 2 weeks through effective treatment such as physiotherapy or self-treatment. A total of 3 patients withdrew because of adverse events. There were 9 types of adverse events related to acupuncture, including subcutaneous haematoma, bleeding, skin bruising and needle site pain. Subcutaneous haematoma and haemorrhage in the needling points were the most common adverse events. Age and gender were related to the occurrence of acupuncture adverse events. The older the patients were, the higher the risk of adverse events was. In addition, male patients had slightly higher risk of an adverse event than female patients. Conclusions: Acupuncture is a safe therapy with low risk of adverse events in clinical practice. The risk factors for adverse events (AEs) were related to the patients' gender and age and the local anatomical structure of the acupoints. AEs could be reduced and mitigated by improving the medical environment, ensuring a high technical level of the acupuncture practitioners and establishing a good relationship of mutual trust between doctor and patient. Trial Registration: ClinicalTrials.gov: NCT00599586, NCT00599677, NCT00608660
Purpose. This study aimed to measure the concentrations of ferroptosis-related biomarkers, namely, iron (Fe), lipid peroxide (LPO), reactive oxygen species (ROS), glutathione peroxidase-4 (GPX4), and glutathione (GSH) in DR in the attempt to evaluate the diagnostic performance of these biomarkers. Methods. This study included 30 NPDR patients, 30 PDR patients, and 30 healthy subjects matched in age and sex. The concentrations of Fe, LPO, ROS, GPX4, and GSH in serum of the subjects were measured. Results. Compared with the normal group, GPX4 and GSH concentrations were significantly lower, and LPO, Fe, and ROS concentrations were significantly higher in DR patients. Compared with the PDR group, the NPDR group had higher concentrations of LPO, Fe, and ROS and lower concentrations of GPX4 and GSH, but there was no statistical difference in Fe, GPX4, and GSH. ROC curve shows that ferroptosis-related biomarkers have accumulated accuracy in NPDR and PDR. Conclusion. This study shows that ferroptosis-related biomarkers may be involved in the pathological process of DR and can be used as one of the biomarkers of DR.
In 2007, the Chinese Science Division of the State Administration of Traditional Chinese Medicine(TCM) convened a special conference to discuss quality control for TCM clinical research. Control and assurance standards were established to guarantee the quality of clinical research. This paper provides practical guidelines for implementing strict and reproducible quality control for acupuncture randomized controlled trials (RCTs).
Introduction: Scutellarin (SCU), a flavonoid with established pharmacological activity, exhibits anti-angiogenic and vascular-stabilizing effects in ischemic ocular diseases.Methods: This study investigated its bidirectional modulation of the vascular endothelial growth factor(VEGF)/Angiopoietin (Ang)/Tie2 signaling pathway in retinal neovascularization (RNV) under hypoxic conditions and compared its efficacy with Faricimab, a dual-target angiogenesis inhibitor. A CoCl2-induced hypoxic model in rat retinal microvascular endothelial cells (rRMECs) was used to evaluate proliferation, migration, and tube formation. Network pharmacology and molecular docking were employed to predict SCU targets and key signaling pathways. Western blotting and qRT-PCR validated its regulatory effects at the molecular level.Results: SCU significantly and dose-dependently suppressed rRMEC proliferation, migration, and tube formation under hypoxia, with effects comparable to those of Faricimab at higher concentrations. Network pharmacology identified 43 overlapping targets between SCU and RNV. Pathway enrichment analysis indicated involvement of VEGF, MAPK, and Ras signaling. Molecular docking showed strong binding of SCU to VEGF-A, Ang2, Tie2, and Vascular endothelial protein tyrosine phosphatase (VE-PTP). SCU downregulated pro-angiogenic factors (VEGF-A, Ang2, HIF-1α, VE-PTP) and upregulated vascular stability-related proteins (Ang1, Tie2, vascular endothelial cadherin (VE-cadherin)) at both mRNA and protein levels.Discussion: These results suggest that SCU exerts a dual regulatory effect on retinal neovascularization by simultaneously inhibiting pathological angiogenesis and enhancing vascular stabilization via the VEGF/Ang/Tie2 signaling pathway. Its mode of action complements and extends the mechanism of Faricimab, supporting its potential as a promising natural candidate for retinal vascular disease therapy.
8 May 2025 in Photodiagnosis and Photodynamic Therapy
Based on optical coherence tomography angiography (OCTA), we investigate the effects of posterior scleral reinforcement surgery on the fundus structure and function in patients with high myopia. Retrospective clinical study. Forty cases (41eyes) of high myopia patients who underwent posterior scleral reinforcement surgery at Chengdu University of Traditional Chinese Medicine Affiliated Silver Eye Hospital from January 2022 to January 2025 were selected. Follow-up periods included postoperative 3 months, 6 months, and 1 year. Key indicators before and after surgery were compared, including best-corrected visual acuity (BCVA), axial length (AL), spherical equivalent (SE), retinal thickness (RT), choroidal thickness (CT), and Superficial retinal capillary plexus density (SCP), deep retinal capillary plexus density (DCP), choroidal vascularity index (CVI), choroidal stromal vascularity index (CSI). The study included 40 patients (41 eyes), comprising 9 male patients (9 eyes) and 31 female patients (32 eyes), with a mean age of 42.05 ± 18.71 years.At the last follow-up, patients showed significantly shortened AL (P<0.001), significantly improved BCVA (P<0.05), and significantly increased CT (P<0.05).SCP also exhibited significant postoperative increases (P<0.05). Additionally,CVI and CSI showed significant postoperative elevation (P<0.05). This study demonstrates that posterior scleral reinforcement achieves axial stabilization through mechanical reinforcement, mitigates vitreous traction forces on the retina and choroid, enhances visual acuity, improves choroidoretinal microcirculation, and optimizes fundus architecture.
Retinal Müller cells (RMCs) play a crucial role in providing structural support and regulating various functions within the retina. As a core component of the retinal microenvironment, RMCs perform several vital functions. Through their abundant ion channels, ligands, receptors, transmembrane transporters, and enzyme systems, these cells contribute to neurotransmitter and trophic factor secretion, regulate retinal metabolism, and maintain water-ion homeostasis. Notably, RMCs have recently been identified as a significant source of endogenous retinal regenerative stem cells, offering novel therapeutic targets for the treatment of retinal degenerative diseases. Therefore, studying RMCs is essential for understanding the pathological mechanisms underlying retinal disorders. This study systematically establishes a standardized experimental protocol that includes trypsin digestion and purification of primary RMCs, morphological observation using inverted optical microscopy and hematoxylin and eosin (HE) staining, specific protein identification through immunofluorescence staining, and cell purity analysis via flow cytometry. This protocol serves as a valuable reference for both basic research and clinical applications related to RMCs, supporting the exploration of their mechanisms in retinal diseases and advancing the development of therapeutic strategies.